Cart
sales@molnova.com
IKK2-IN-8
CAS No. 1266240-87-2
IKK2-IN-8( —— )
Catalog No. M11119 CAS No. 1266240-87-2
IKK2-IN-8 is a potent, selective IKK2 inhibitor with IC50 of 6 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameIKK2-IN-8
-
NoteResearch use only, not for human use.
-
Brief DescriptionIKK2-IN-8 is a potent, selective IKK2 inhibitor with IC50 of 6 nM.
-
DescriptionIKK2-IN-8 is a potent, selective IKK2 inhibitor with IC50 of 6 nM, displays >40-fold selectivity over IKK1 (IC50=230 nM); inhibits lipopolysaccharide (LPS) induced TNFα production in human PBMCs with IC50 of 80 nM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetIκB kinase (IKK)
-
RecptorIκB kinase (IKK)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1266240-87-2
-
Formula Weight380.47
-
Molecular FormulaC19H20N6OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name(S)-N-(1-(3-(8-methyl-5-(methylamino)-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridin-2-yl)phenyl)ethyl)acetamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Dyckman AJ, et al. Bioorg Med Chem Lett. 2011 Jan 1;21(1):383-6.
molnova catalog
related products
-
IKK16
IKK16 is a potent, selective inhibitor of IκB kinase (IKK) with IC50 of 40, 70 and 200 nM for IKKβ, IKK complex and IKKα respectively.
-
BAY-985
BAY-985 is a potent, selective, and orally active ATP-competitive dual inhibitor of TBK1 and IKKε (IC50s: 2/30 and 2 nM for TBK1 (low/high ATP) and IKKε) with antitumor efficacy.BAY-985 inhibits FLT3, RSK4, DRAK1, and ULK1 (IC50s: 123, 276, 311, and 7930 nM). BAY-985 inhibits the cellular phosphorylation of interferon regulatory factor 3 (IRF3, IC50: 74 nM).
-
AZD3264
A novel IkB-kinase IKK2 inhibitor for treatment of inflammatory conditions such as asthma, chronic pulmonary obstructive disorder (COPD) and rheumatoid arthritis.
